London Stock Exchange Group Reports Income Growth Driven by Tradewebs Strong Performance Trump Postpones AI Executive Order Signing Citing Concerns Over Potential Blocker Effect Alain Prost Injured in Home Raid Security Concerns for HighProfile Figures Deutsche Bank Maintains Positive Stance on Salesforce as Citi Adjusts Price Target Lower Iran Pursues Diplomatic Path Seeking Economic Relief While Avoiding Political Boost for Trump Cybersecurity Jobs Surge 11 as AI Era Drives Demand for Digital Protection CISO Q2 2025 Earnings EPS of 009 as Shares Decline BILI Q1 2026 Earnings EPS Surpasses Estimates by 135 Stock Gains Accelerant Holdings ARX Q1 2026 Earnings EPS Beat Drives Positive Investor Sentiment PSMT Q1 2026 Earnings EPS Beats Estimates by 28 as Stock Barely Moves STKS Q1 2026 Earnings Significant EPS Miss Amid Challenging Environment Red Violet RDVT Q1 2026 Earnings Strong EPS Beat Drives Stock Higher Rogers Communications RCI Gains 148 as Shares Approach Resistance at 3905 Organigram Global OGI Holds Steady Near Support Amid Cautious Cannabis Sector Sentiment SPACSphere Acquisition Corp SSAC Holds Steady at 995 Testing Key Technical Juncture Guardforce AI GFAI Holds Near Support as Selling Pressure Eases Sabine Royalty Trust SBR Edges Lower Key Levels and Market Dynamics Serina Therapeutics SER Faces Headwinds Shares Decline 3 Toward Support at 182 Weave Communications WEAV Holds Steady Near Resistance Following Modest Uptick Barings Participation Investors MPV Gains 146 Testing Key Resistance at 1805 UBX Technology Ltd UBXG Surges 84 Breaking Above Key Support Level ALX Oncology Holdings ALXO Holds Steady Near Support as Biotech Sector Watches Catalyst Calendar SpaceXs Public Debut Raises Sector Classification Question Industrials Tech or Telecommunications IRM Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response Planet Green Holdings PLAG Edges Higher Key Resistance Looms at 166 CW Q1 2026 Earnings EPS Surpasses Estimates Stock Edges Higher ODYS Q1 2026 Earnings EPS Misses Estimates as Company Focuses on Product Development XCUR Q2 2022 Earnings EPS Miss Widens as PreRevenue Biotech Shares Edge Higher TFPM Q1 2026 Earnings EPS Surpasses Estimates as Royalty Performance Drives Results CEPT Q1 2026 Earnings EPS Surges 96 Above Estimates Amid Investment Gains SON Q1 2026 Earnings EPS Slightly Misses Estimates Amid Mixed Market Signals Annovis Bio Q1 2026 Earnings EPS Misses Estimates as PreClinical Spending Intensifies